Mark has worked in the pharma industry for over 25 years. Mark is currently VP, Head of Site Management Americas Region. His oversight includes Canada, the US and LATAM. His group is responsible for all Phase I-III clinical trials across various therapeutic areas including Cardiovascular, Women’s Healthcare & Oncology. Prior to his time at Bayer, Mark was a study coordinator at a clinical research site. Mark holds a BA in Psychology from Penn State University and an MBA from the University of New Haven.